FABP1 and metabolic disease: Studies in young adults agreed that low HDL cholesterol levels and hypertriglyceridemia were associated with serum FABP1 levels, suggesting it as a possible circulating biomarker of adiposity and metabolic diseases associated with insulin resistance, involved in hepatic lipid binding and lipid metabolism (Shi et al., 2012).